Furthermore, GSEA analysis revealed a robust relationship between TPM4 and EMT phenotype, which had been identified as a vital process in tumor migration, invasion, recurrence, and therapeutic resistance in glioma cells [26,27,28]. Here, TPM4 is linked to central nervous system cancer.